Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

Trial Profile

Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2016

At a glance

  • Drugs Fluvastatin (Primary) ; Pimonidazole
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Jun 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Sep 2016.
    • 21 Dec 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top